Developed go-to-market strategy for follow-on asset with blockbuster potential

Client issue
Our client sought to develop an “agile launch” approach to commercialize its second-generation diabetes asset considering competitor pressures and anticipated U.S. market access challenges.

CRA approach
We conducted internal interviews and applied advanced analytics to “fingerprint” U.S. regions most likely to be amenable to the new asset’s launch. We then conducted a series of cross-functional working sessions to build buy-in for a new go-to-market model and developed function-level strategies and execution guidance.

Client impact
The client implemented changes in resource deployment, skills training, incentive compensation, and various non-personal and market access investments.